"Beyond pharmaceuticals, this model will unlock limitless possibilities across many other industries, driving biological discoveries in ways we are only beginning to imagine," said co-founder and CEO Jean-Philippe Vert. "Essentially, it's like the GPT of biology-but instead of generating text, we're simulating biology."
Co-founder and CEO Jean-Philippe Vert emphasizes the significance of developing a foundational AI model for biology to enable scientists to simulate the biological world and predict disease outcomes.
Collection
[
|
...
]